$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 47.98 | 212 | 10,172 | 14,420 | 14.6 K to 14.4 K (-1.45 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 47.97 | 354 | 16,981 | 14,632 | 15 K to 14.6 K (-2.36 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 47.95 | 71 | 3,404 | 14,986 | 15.1 K to 15 K (-0.47 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 6.75 | 4,167 | 28,127 | 15,057 | 10.9 K to 15.1 K (+38.26 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 5,655 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.74 | 16 | 780 | 4,899 | 4.9 K to 4.9 K (-0.33 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.66 | 78 | 3,795 | 4,915 | 5 K to 4.9 K (-1.56 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.65 | 280 | 13,622 | 4,993 | 5.3 K to 5 K (-5.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.64 | 16 | 778 | 5,273 | 5.3 K to 5.3 K (-0.30 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.60 | 15 | 729 | 5,289 | 5.3 K to 5.3 K (-0.28 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.58 | 156 | 7,578 | 5,304 | 5.5 K to 5.3 K (-2.86 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.57 | 280 | 13,600 | 5,260 | 5.5 K to 5.3 K (-5.05 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.50 | 341 | 16,539 | 5,740 | 6.1 K to 5.7 K (-5.61 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.45 | 16 | 775 | 6,081 | 6.1 K to 6.1 K (-0.26 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.41 | 31 | 1,501 | 6,097 | 6.1 K to 6.1 K (-0.51 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.40 | 140 | 6,776 | 6,128 | 6.3 K to 6.1 K (-2.23 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.37 | 264 | 12,770 | 6,268 | 6.5 K to 6.3 K (-4.04 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.29 | 121 | 5,843 | 6,532 | 6.7 K to 6.5 K (-1.82 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.03 | 31 | 1,489 | 6,653 | 6.7 K to 6.7 K (-0.46 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.02 | 140 | 6,723 | 6,684 | 6.8 K to 6.7 K (-2.05 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.01 | 187 | 8,978 | 6,824 | 7 K to 6.8 K (-2.67 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.00 | 140 | 6,720 | 7,011 | 7.2 K to 7 K (-1.96 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.99 | 78 | 3,743 | 7,151 | 7.2 K to 7.2 K (-1.08 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.98 | 140 | 6,717 | 7,229 | 7.4 K to 7.2 K (-1.90 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.97 | 233 | 11,177 | 7,369 | 7.6 K to 7.4 K (-3.06 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.95 | 47 | 2,254 | 7,602 | 7.6 K to 7.6 K (-0.61 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,649 | 4.9 K to 7.6 K (+56.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Grant | A | 58.16 | 10 | 582 | 4,899 | 4.9 K to 4.9 K (+0.20 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | VP, Global Reg. Aff ... | Grant | A | 58.16 | 10 | 582 | 3,415 | 3.4 K to 3.4 K (+0.29 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 33,500 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.74 | 8 | 390 | 2,890 | 2.9 K to 2.9 K (-0.28 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.66 | 42 | 2,044 | 2,898 | 2.9 K to 2.9 K (-1.43 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.65 | 153 | 7,443 | 2,940 | 3.1 K to 2.9 K (-4.95 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.64 | 8 | 389 | 3,093 | 3.1 K to 3.1 K (-0.26 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.60 | 8 | 389 | 3,101 | 3.1 K to 3.1 K (-0.26 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.58 | 85 | 4,129 | 3,109 | 3.2 K to 3.1 K (-2.66 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.57 | 154 | 7,480 | 3,194 | 3.3 K to 3.2 K (-4.60 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.50 | 187 | 9,070 | 3,348 | 3.5 K to 3.3 K (-5.29 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.45 | 9 | 436 | 3,535 | 3.5 K to 3.5 K (-0.25 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.41 | 17 | 823 | 3,544 | 3.6 K to 3.5 K (-0.48 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.40 | 76 | 3,678 | 3,561 | 3.6 K to 3.6 K (-2.09 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.37 | 145 | 7,014 | 3,637 | 3.8 K to 3.6 K (-3.83 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.29 | 65 | 3,139 | 3,782 | 3.8 K to 3.8 K (-1.69 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.03 | 17 | 817 | 3,847 | 3.9 K to 3.8 K (-0.44 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.02 | 76 | 3,650 | 3,864 | 3.9 K to 3.9 K (-1.93 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.01 | 102 | 4,897 | 3,940 | 4 K to 3.9 K (-2.52 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 48.00 | 77 | 3,696 | 4,042 | 4.1 K to 4 K (-1.87 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.99 | 42 | 2,016 | 4,119 | 4.2 K to 4.1 K (-1.01 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.98 | 76 | 3,646 | 4,161 | 4.2 K to 4.2 K (-1.79 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.97 | 128 | 6,140 | 4,237 | 4.4 K to 4.2 K (-2.93 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.95 | 25 | 1,199 | 4,365 | 4.4 K to 4.4 K (-0.57 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 4,390 | 2.9 K to 4.4 K (+51.90 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 30.74 | 900 | 27,666 | 42,800 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.74 | 5 | 244 | 4,544 | 4.5 K to 4.5 K (-0.11 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.66 | 25 | 1,217 | 4,549 | 4.6 K to 4.5 K (-0.55 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.65 | 92 | 4,476 | 4,574 | 4.7 K to 4.6 K (-1.97 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.64 | 5 | 243 | 4,666 | 4.7 K to 4.7 K (-0.11 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.60 | 5 | 243 | 4,671 | 4.7 K to 4.7 K (-0.11 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.58 | 51 | 2,478 | 4,676 | 4.7 K to 4.7 K (-1.08 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.57 | 92 | 4,468 | 4,727 | 4.8 K to 4.7 K (-1.91 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.50 | 112 | 5,432 | 4,819 | 4.9 K to 4.8 K (-2.27 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.45 | 3 | 145 | 4,931 | 4.9 K to 4.9 K (-0.06 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.41 | 10 | 484 | 4,934 | 4.9 K to 4.9 K (-0.20 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.40 | 46 | 2,226 | 4,944 | 5 K to 4.9 K (-0.92 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.37 | 88 | 4,257 | 4,990 | 5.1 K to 5 K (-1.73 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.29 | 41 | 1,980 | 5,078 | 5.1 K to 5.1 K (-0.80 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.03 | 10 | 480 | 5,119 | 5.1 K to 5.1 K (-0.19 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.02 | 46 | 2,209 | 5,129 | 5.2 K to 5.1 K (-0.89 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.01 | 61 | 2,929 | 5,175 | 5.2 K to 5.2 K (-1.17 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 48.00 | 46 | 2,208 | 5,236 | 5.3 K to 5.2 K (-0.87 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 47.99 | 25 | 1,200 | 5,282 | 5.3 K to 5.3 K (-0.47 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 47.98 | 46 | 2,207 | 5,307 | 5.4 K to 5.3 K (-0.86 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 47.97 | 76 | 3,646 | 5,353 | 5.4 K to 5.4 K (-1.40 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 47.95 | 15 | 719 | 5,429 | 5.4 K to 5.4 K (-0.28 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 30.74 | 900 | 27,666 | 5,444 | 4.5 K to 5.4 K (+19.81 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Grant | A | 58.16 | 10 | 582 | 4,544 | 4.5 K to 4.5 K (+0.22 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Grant | A | 58.16 | 10 | 582 | 10,265 | 10.3 K to 10.3 K (+0.10 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 6.88 | 8,300 | 57,063 | 41,000 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.74 | 47 | 2,291 | 34,199 | 34.2 K to 34.2 K (-0.14 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.66 | 235 | 11,435 | 34,246 | 34.5 K to 34.2 K (-0.68 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.65 | 845 | 41,109 | 34,481 | 35.3 K to 34.5 K (-2.39 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.64 | 46 | 2,237 | 35,326 | 35.4 K to 35.3 K (-0.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.60 | 46 | 2,236 | 35,372 | 35.4 K to 35.4 K (-0.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.58 | 470 | 22,833 | 35,418 | 35.9 K to 35.4 K (-1.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.57 | 847 | 41,139 | 35,888 | 36.7 K to 35.9 K (-2.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.50 | 1,033 | 50,101 | 36,735 | 37.8 K to 36.7 K (-2.74 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.45 | 47 | 2,277 | 37,768 | 37.8 K to 37.8 K (-0.12 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.41 | 94 | 4,551 | 37,815 | 37.9 K to 37.8 K (-0.25 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.40 | 423 | 20,473 | 37,909 | 38.3 K to 37.9 K (-1.10 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.37 | 797 | 38,551 | 38,332 | 39.1 K to 38.3 K (-2.04 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.29 | 365 | 17,626 | 39,129 | 39.5 K to 39.1 K (-0.92 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.03 | 94 | 4,515 | 39,494 | 39.6 K to 39.5 K (-0.24 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.02 | 423 | 20,312 | 39,588 | 40 K to 39.6 K (-1.06 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.01 | 563 | 27,030 | 40,011 | 40.6 K to 40 K (-1.39 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.00 | 422 | 20,256 | 40,574 | 41 K to 40.6 K (-1.03 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.99 | 235 | 11,278 | 40,996 | 41.2 K to 41 K (-0.57 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.98 | 423 | 20,296 | 41,231 | 41.7 K to 41.2 K (-1.02 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.97 | 704 | 33,771 | 41,654 | 42.4 K to 41.7 K (-1.66 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.95 | 141 | 6,761 | 42,358 | 42.5 K to 42.4 K (-0.33 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 6.88 | 8,300 | 57,063 | 42,499 | 34.2 K to 42.5 K (+24.27 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Option Exercise | M | 21.55 | 4,500 | 96,975 | 3,334 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 48.30 | 2,875 | 138,863 | 3,280 | 6.2 K to 3.3 K (-46.71 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Buy | M | 21.55 | 4,500 | 96,975 | 6,155 | 1.7 K to 6.2 K (+271.90 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Grant | A | 58.16 | 10 | 582 | 1,655 | 1.6 K to 1.7 K (+0.61 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 61 | 1,315 | 3,200 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.74 | 1 | 49 | 10 | 11 to 10 (-9.09 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.66 | 2 | 97 | 11 | 13 to 11 (-15.38 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.65 | 6 | 292 | 13 | 19 to 13 (-31.58 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.64 | 1 | 49 | 19 | 20 to 19 (-5.00 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.60 | 2 | 97 | 20 | 22 to 20 (-9.09 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.58 | 2 | 97 | 22 | 24 to 22 (-8.33 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.57 | 3 | 146 | 24 | 27 to 24 (-11.11 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.50 | 8 | 388 | 27 | 35 to 27 (-22.86 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.45 | 1 | 48 | 35 | 36 to 35 (-2.78 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.41 | 1 | 48 | 36 | 37 to 36 (-2.70 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.40 | 3 | 145 | 37 | 40 to 37 (-7.50 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.37 | 6 | 290 | 40 | 46 to 40 (-13.04 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.29 | 3 | 145 | 46 | 49 to 46 (-6.12 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.03 | 1 | 48 | 49 | 50 to 49 (-2.00 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.02 | 3 | 144 | 50 | 53 to 50 (-5.66 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.01 | 4 | 192 | 53 | 57 to 53 (-7.02 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 48.00 | 3 | 144 | 57 | 60 to 57 (-5.00 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 47.99 | 2 | 96 | 60 | 62 to 60 (-3.23 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 47.98 | 3 | 144 | 62 | 65 to 62 (-4.62 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 47.97 | 5 | 240 | 65 | 70 to 65 (-7.14 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 47.95 | 1 | 48 | 70 | 71 to 70 (-1.41 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | M | 21.55 | 61 | 1,315 | 71 | 132 to 71 (-46.21 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Grant | A | 58.16 | 10 | 582 | 10 | 0 to 10 |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 6.75 | 2,501 | 16,882 | 12,499 | |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 6.50 | 15,000 | 97,500 | 0 | |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 9.25 | 7,499 | 69,366 | 0 | |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 50.20 | 7,980 | 400,596 | 10,890 | 18.9 K to 10.9 K (-42.29 %) |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 50.08 | 3,390 | 169,771 | 18,870 | 22.3 K to 18.9 K (-15.23 %) |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 50.00 | 22,630 | 1,131,500 | 22,260 | 44.9 K to 22.3 K (-50.41 %) |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 6.75 | 2,501 | 16,882 | 44,890 | 42.4 K to 44.9 K (+5.90 %) |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 6.50 | 15,000 | 97,500 | 42,389 | 27.4 K to 42.4 K (+54.77 %) |
Nov 29 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 9.25 | 7,499 | 69,366 | 27,389 | 19.9 K to 27.4 K (+37.70 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 3,700 | 88,245 | 80,000 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.83 | 124 | 8,039 | 10,255 | 10.4 K to 10.3 K (-1.19 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.60 | 132 | 8,527 | 10,379 | 10.5 K to 10.4 K (-1.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.54 | 14 | 904 | 10,511 | 10.5 K to 10.5 K (-0.13 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.53 | 14 | 903 | 10,525 | 10.5 K to 10.5 K (-0.13 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.52 | 55 | 3,549 | 10,539 | 10.6 K to 10.5 K (-0.52 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.49 | 35 | 2,257 | 10,594 | 10.6 K to 10.6 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.40 | 28 | 1,803 | 10,629 | 10.7 K to 10.6 K (-0.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.33 | 534 | 34,352 | 10,657 | 11.2 K to 10.7 K (-4.77 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.32 | 519 | 33,382 | 11,191 | 11.7 K to 11.2 K (-4.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.31 | 214 | 13,762 | 11,710 | 11.9 K to 11.7 K (-1.79 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.30 | 625 | 40,188 | 11,924 | 12.5 K to 11.9 K (-4.98 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.28 | 100 | 6,428 | 12,549 | 12.6 K to 12.5 K (-0.79 %) |